VivoSeq
Other

Vasoconstriction

0

Pipeline Programs↗

2

Active Trials↗

4

Companies Involved↗

Vasoconstriction is an early-stage landscape with 0 programs across 4 companies. The most active players are diana garcia, LEO Pharma, Sun Pharmaceutical Industries, Inc..

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

94/100

Attrition Rate

5/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

D

diana garcia

1 program

PreclinicalLEO Pharma logo

LEO Pharma

0 programs

PreclinicalSun Pharmaceutical Industries, Inc. logo

Sun Pharmaceutical Industries, Inc.

0 programs

PreclinicalM

MC2 Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

21

clinical trials

Completed17 · 81%
Unknown status1 · 5%
Withdrawn1 · 5%
Recruiting1 · 5%
Not yet recruiting1 · 5%

Clinical Trials

Trial Activity

21 trials

Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans
Recruiting·UUniversity of Calgary·N/A·NCT05442463·200 enrolled
ESTAR-VR Project: Randomized Controlled Trial on the Impact of Virtual Reality on Reducing Stress, Anxiety, and Pain During Invasive Procedures
Not yet recruiting·—·Preclinical·NCT07696156·202 enrolled
Local Antioxidant Therapy Vasoconstriction Effects in Different Races
Completed·TThe University of Texas at Arlington·Phase 1·NCT03684213·22 enrolled
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
Completed·TThe University of Texas at Arlington·Phase 1·NCT03679780·19 enrolled
Impact of Insulin on Sympathetic Nervous System-mediated Peripheral Vasoconstriction
Completed·UUniversity of Missouri-Columbia·Phase 1·NCT05244694·28 enrolled
A Vasoconstriction Study With LEO 90100
Completed·LEO Pharma logoLEO Pharma·Phase 1·NCT01946386·35 enrolled
Evidence of Spreading Vasoconstriction in Human Gingiva
Completed·SSemmelweis University·N/A·NCT04131283·29 enrolled
The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
Completed·TThe University of Texas at Arlington·Phase 1·NCT03680404·24 enrolled
Vasoconstriction Trial With LEO 90100 Aerosol Foam
Completed·LEO Pharma logoLEO Pharma·Phase 1·NCT02973776·36 enrolled
Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans
Completed·MMedical University of Vienna·N/A·NCT02221089·40 enrolled
Xylometazoline and Cocaine for Nasal Vasoconstriction
Completed·—·Phase 4·NCT05334017·120 enrolled
Effect of DPP4 Inhibition on Vasoconstriction
Completed·VVanderbilt University·Phase 4·NCT02639637·18 enrolled
Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
Completed·Sun Pharmaceutical Industries, Inc. logoSun Pharmaceutical Industries, Inc.·Phase 1·NCT04358770·124 enrolled
Evaluation of the Vasoconstriction Properties of MC2-01 Cream
Completed·MMC2 Therapeutics·Phase 1·NCT03758365·36 enrolled
Comparison of Topical Vasoconstriction in Endoscopic Sinus Surgery
Completed·—·Phase 4·NCT01706952·45 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)